NuScale Power Directors’ Phantom Stock Purchase Signals Long‑Term Confidence Amid Insider Buy‑In Surge

Insider Activity Signals a Strategic Shift at NuScale

Recent filings reveal that non‑employee director Kresa Kent has acquired 3,946 phantom shares on March 31, 2026. The transaction is not a cash purchase but a deferred‑compensation award tied to class‑A common stock, vesting upon separation. While the amount is modest compared with the large block trades executed by senior executives in early March, it underscores a deliberate effort to align director incentives with long‑term shareholder value rather than short‑term price movements.

What This Means for Investors

Phantom stock is a common tool for rewarding directors without diluting equity, yet it signals confidence in the company’s future cash flows. Kent’s purchase comes after a week of high‑volume insider buying by the CEO and other officers, suggesting a unified front on the company’s strategic trajectory. For shareholders, this could mean tighter governance and a clearer path to monetizing the SMR platform, potentially smoothing the volatile price swings that have plagued the stock since its peak in October 2025.

Assessing the Broader Insider Trend

The March 2026 insider activity is dominated by significant equity purchases and sales by the CEO, COO, and CTO, with total buy volumes exceeding 150 k shares. The pattern indicates an aggressive build‑out of personal holdings during a period of rising SMR demand in Europe and the U.K., while also reflecting a readiness to sell in the event of adverse market conditions. Kent’s phantom stock aligns with this trend, offering a low‑risk, long‑term stake that could mature as the company secures new regulatory approvals.

Kresa Kent’s Historical Profile

Kent’s transaction history is sparse: the last trade in September 2025 involved a purchase of 1,262 class‑A shares at $36.00, raising her holding to 82,578 shares. The March 2026 phantom‑stock award is her first derivative transaction since then. This pattern suggests a cautious, long‑term investor who prefers to accumulate equity gradually. Her recent move indicates a belief that the SMR market will expand, but she is also mindful of liquidity needs, hence the choice of phantom stock that avoids immediate cash outlay.

Strategic Outlook for NuScale

With the company facing potential litigation and a negative price‑earnings ratio, insider buying signals that leadership is not yet rattled. The infusion of phantom stock could reinforce governance stability and reassure investors that directors are committed to a medium‑term horizon. For analysts, the key metrics to watch are the company’s capital‑expenditure plans for SMR deployment and the resolution of the securities‑fraud lawsuit. If the legal issues are contained and regulatory support continues, the stock could rebound, benefiting those who have quietly built positions in the past few months.